«

»

Biortus Gets $15 Mln From Pharmaron-Backed Bayland Capital

The COVID-19 pandemic has put a spotlight on China's pharmaceutical industry.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive